STOCK TITAN

Kamada (KMDA) grants director 30,000 stock options at $7.52 exercise price

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kamada Ltd director Lilach Asher-Topilsky received a grant of 30,000 employee stock options to buy ordinary shares at an exercise price of $7.52 per share, presented in U.S. dollars based on an NIS exchange rate. The options vest in four equal annual installments over four years, are exercisable for ten years from grant, and are held indirectly by a trustee under Kamada's 2011 Share Award Plan.

Positive

  • None.

Negative

  • None.
Insider Asher-Topilsky Lilach
Role Director
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) F1, F2, F3 30,000 $0.00 $0.00
Holdings After Transaction: Employee Stock Option (right to buy) — 30,000 shares (Indirect, Held by trustee)
Footnotes (3)
  1. F1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
  2. F2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
  3. F3. Held by trustee under the Company's 2011 Share Award Plan.
Options Granted 30,000 options Employee Stock Option grant to director Lilach Asher-Topilsky
Exercise Price $7.5200 per share Exercise price for the granted employee stock options, converted from NIS
Underlying Ordinary Shares 30,000 shares Ordinary Shares underlying the Employee Stock Option grant
Vesting Period 4 years Options vest in four equal annual installments of 25% each
Option Term 10 years Options exercisable for ten years from grant; unexercised options then expire
Total Options After Grant 30,000 options Total Employee Stock Options held indirectly following this reported transaction
Transaction Date 2026-08-05 Grant date of the Employee Stock Option award
Employee Stock Option financial
"Security title is "Employee Stock Option (right to buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
exercise price financial
"The exercise price presented in U.S. dollars represent a convenience conversion"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The options will vest over a period of four years in four equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Share Award Plan financial
"Held by trustee under the Company's 2011 Share Award Plan."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction in KMDA stock did Lilach Asher-Topilsky report on this Form 4?

Lilach Asher-Topilsky reported receiving 30,000 employee stock options to purchase Kamada ordinary shares. The options were granted at an exercise price of $7.52 per share, providing the right, but not the obligation, to buy shares in the future under specified terms.

What is the exercise price of the stock options granted to the KMDA director?

The granted options carry an exercise price of $7.52 per share. This price is presented in U.S. dollars as a convenience conversion from NIS, using the exchange rate published by the Bank of Israel as of August 4, 2026, according to the footnotes.

How do the 30,000 KMDA stock options granted to Lilach Asher-Topilsky vest?

The 30,000 options vest over four years in four equal installments. 25% of the options vest on each anniversary of the grant date, creating annual vesting events rather than immediate vesting, which links full benefit to continued service over the vesting period.

For how long are the KMDA stock options granted to the director exercisable?

The options are exercisable for a period of 10 years following the grant date. Any options not exercised by the end of this ten-year term expire immediately thereafter, meaning the right to purchase shares under these options ends at that time.

How are Lilach Asher-Topilsky's KMDA options held and under which plan?

The 30,000 options are held indirectly by a trustee under Kamada's 2011 Share Award Plan. This means the reporting person's interest is classified as indirect ownership, with the trustee administering the options in accordance with the terms of the company plan.

Were the reported KMDA option transactions under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as affirmed. The filing does not state that this option grant was made pursuant to a Rule 10b5-1 trading plan, so it is presented simply as a compensation-related grant or award acquisition.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Asher-Topilsky Lilach

(Last)(First)(Middle)
94 YIGAL ALON ST.,
ALON TOWER 2.

(Street)
TEL AVIV

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$7.52(1)08/05/2026A30,000 (2) (2)Ordinary Shares30,000$0.0030,000IHeld by trustee(3)
Explanation of Responses:
1. The exercise price presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of August 4, 2026.
2. The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.
3. Held by trustee under the Company's 2011 Share Award Plan.
/s/ Lilach Asher Topilsky08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)